Nebulized hypertonic saline 3% for 1 versus 3 days in hospitalized bronchiolitis: a blinded non-inferiority randomized controlled trial

BACKGROUND: The use and optimal duration of treatment with nebulized hypertonic saline (HS) in infants hospitalized for acute bronchiolitis is unclear. The objective was to compare the efficacy of 1 versus 3 days of nebulized 3% HS at 72 h of treatment. We conducted a blinded non-inferiority randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Beal, Gaëlle, Barbier, Catherine, Thoret, Sophie, Rubio, Amandine, Bonnet, Mathilde, Mazet, Roseline, Ego, Anne, Pin, Isabelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839239/
https://www.ncbi.nlm.nih.gov/pubmed/31699072
http://dx.doi.org/10.1186/s12887-019-1804-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839239/
https://www.ncbi.nlm.nih.gov/pubmed/31699072
http://dx.doi.org/10.1186/s12887-019-1804-0

Ejemplares similares